| Business Summary | | Alcide
Corporation
is
engaged
in
the
research,
development
and
commercialization
of
unique
chemical
compounds
having
intense
microbiocidal
activity.
The
Company
holds
substantial
worldwide
rights
to
its
discoveries
through
various
patents,
patent
applications,
trademarks
and
other
intellectual
property,
technology,
and
know-how.
The
Company
presently
sells
products
to
the
dairy,
health
care
and
poultry
processing
industries. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Alcide
is
engaged
in
the
research,
development,
and
commercialization
of
unique
chemical
compounds
having
intense
microbiocidal
activity,
sold
primarily
to
the
dairy,
health
care,
poultry
processing
and
automotive
industries.
For
the
fiscal
year
ended
5/01,
net
sales
rose
44%
to
$18
million.
Net
income
totaled
$1.5
million
vs.
a
loss
of
$447
thousand.
Results
reflect
higher
sales
of
SANOVA
food
antimicrobial.
Net
income
also
reflects
improved
gross
margins
at
SANOVA. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Joseph Sasenick, 61 Chairman,
CEO | $343K | $59K | John Richards, 58 Pres | 223K | 35K | G. Kere Kemp, 50 Exec.
VP and CSO | 172K | -- | Dollar amounts are as of 31-May-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|